[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555995":3},{"organization":4,"outcomesModule":7,"designInfo":24,"detailedDescription":11,"studyPopulation":11,"armGroups":30,"interventions":37,"overallOfficials":11,"centralContacts":43,"locations":52,"responsibleParty":86,"collaborators":11,"id":88,"slug":11,"hasResults":89,"nctId":90,"briefTitle":91,"officialTitle":92,"acronym":93,"eligibilityCriteria":94,"healthyVolunteers":89,"sex":95,"minAge":96,"maxAge":11,"enrollmentInfo":97,"targetDuration":11,"studyType":100,"phases":101,"briefSummary":102,"conditions":103,"keywords":105,"overallStatus":55,"whyStopped":11,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":118},{"fullName":5,"class":6},"Echosens","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Reduced intra-examination dispersion of liver stiffness measurements with the new measurement method.",null,"24 months",[14,17,20,22],{"measure":15,"description":16,"timeFrame":12},"Bias between the different stiffness measurements (reference\u002Festimated reference\u002Fat rest)","Correlation coefficients will be done.",{"measure":18,"description":19,"timeFrame":12},"Bias between the estimated reference stiffness repetitions and between the stiffness at rest repetitions.","Intra-class correlation coefficients will be done.",{"measure":21,"description":16,"timeFrame":12},"Bias between the CAP measured with the Research FibroScan and the CAP measured with the Reference FibroScan",{"measure":23,"description":19,"timeFrame":12},"Bias between the CAP repetitions done with the Research FibroScan",{"allocation":25,"interventionModel":26,"interventionModelDescription":11,"primaryPurpose":27,"observationalModel":11,"timePerspective":11,"maskingInfo":28},"NA","SINGLE_GROUP","OTHER",{"masking":29,"maskingDescription":11,"whoMasked":11},"NONE",[31],{"label":32,"type":33,"description":34,"interventionNames":35},"Adult patient (age >= 18 y.o) followed for a liver disease, all etiologies combined","EXPERIMENTAL","Adult patients followed in the Hepatology or Endocrinology department for a liver disease, suspected chronic liver disease or consequences of chronic liver disease, all etiologies combined.",[36],"Device: Research FibroScan (FS)",[38],{"type":39,"name":40,"description":41,"armGroupLabels":42,"otherNames":11},"DEVICE","Research FibroScan (FS)","Patients #1 to #25:\n\nExam 1: Examination with Research FibroScan. Exam 2: Examination with the Reference FibroScan at the same measurement point and with the same probe used for the Exam 1.\n\nPatients #26 to #75:\n\nExam 1: Examination with the Research or Reference FibroScan. Exam 2: Examination with the Reference or Research FibroScan at the same measurement point and with the same probe used for the Exam 1.\n\nPatients #76 to #114:\n\nExams 1 \\& 2: 2 consecutive examinations with the Research or Reference FibroScan.\n\nExams 3 \\& 4: 2 consecutive examinations with the Reference or Research FibroScan at the same measurement point and with the same probe used for the Exams 1 \\& 2.",[32],[44,49],{"name":45,"role":46,"phone":47,"phoneExt":11,"email":48},"Anne Llorca","CONTACT","+33144827850","anne.llorca@echosens.com",{"name":50,"role":46,"phone":47,"phoneExt":11,"email":51},"Laura Cantu-Sanchez","laura.cantusanchez@echosens.com",[53,71],{"facility":54,"status":55,"city":56,"state":11,"zip":57,"country":58,"countryCode":59,"cosmosGeoPoint":60,"geoPoint":65,"contacts":66},"Groupe Hospitalier Nord Essonne - Site Paris- Saclay","RECRUITING","Orsay","91400","France","FR",{"type":61,"coordinates":62},"Point",[63,64],2.18727,48.69572,{"lat":64,"lon":63},[67],{"name":68,"role":46,"phone":69,"phoneExt":11,"email":70},"Edoardo Poli, Dr","+33 1 69 15 91 01","e.poli@gh-nord-essonne.fr",{"facility":72,"status":55,"city":73,"state":74,"zip":75,"country":58,"countryCode":59,"cosmosGeoPoint":76,"geoPoint":80,"contacts":81},"Hôpital Pitié-Salpêtrière","Paris","Île-de-France Region","75013",{"type":61,"coordinates":77},[78,79],2.3488,48.85341,{"lat":79,"lon":78},[82],{"name":83,"role":46,"phone":84,"phoneExt":11,"email":85},"Vlad Ratziu, Pr","+33 1 42 17 76 22","vlad.ratziu@inserm.fr",{"type":87,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100555995",false,"NCT06519331","Development of a New Method for Liver Stiffness Measurement Using FibroScan","M148 - Development of a New Method for Liver Stiffness Measurement Using FibroScan","M148","Inclusion Criteria:\n\n* Adult patients (≥ 18 years of age) followed in the hepatology or endocrinology department for liver disease, suspected liver disease or consequences of liver disease, all etiologies combined.\n* Adult patient able to give his written consent\n* Patient affiliated to the French Social Security system\n\nExclusion Criteria:\n\n* Vulnerable patients\n* Patients with liver ascites\n* Patients with heart failure","ALL","18 Years",{"count":98,"type":99},114,"ESTIMATED","INTERVENTIONAL",[25],"This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 114 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan.",[104],"Liver Diseases",[106,107,108],"FibroScan","Vibration Controlled Transient Elastography","Liver Stiffness Measurement","2025-08-11",{"date":111,"type":112},"2025-08-14","ACTUAL",{"date":114,"type":112},"2024-11-08",{"date":116,"type":99},"2027-05-31",{"name":5,"class":6},2]